FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein
FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein
SMPD1; NPD; SMase; aSMase; Sphingomyelin Phosphodiesterase 1,Acid Lysosomal; Simply Sphingomyelinase
SMPD1; NPD; SMase; aSMase; Sphingomyelin Phosphodiesterase 1,Acid Lysosomal; Simply Sphingomyelinase
CLEVER1; FEEL1; FELE1; FEX1; STAB1; MS1 Antigen; Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1
CLEVER1; FEEL1; FELE1; FEX1; STAB1; MS1 Antigen; Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1
MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125
MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125
NMP22; NUMA; Nuclear matrix protein-22; SP-H antigen
NMP22; NUMA; Nuclear matrix protein-22; SP-H antigen